Publication | Closed Access

Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR

MedicineImmunologyDiagnosisPathologyRespiratory InfectionInfectious Respiratory DiseaseCancer PatientsQuantitative PcrLung CancerPulmonary DiseaseSuboptimal Performance